A Single Arm Single Centre Study To Investigate Safety And Efficacy Of Sildenafil In Near Term And Term Newborns With Persistent Pulmonary Hypertension Of The Newborn (PPHN)
Latest Information Update: 21 Jul 2022
At a glance
- Drugs Sildenafil (Primary)
- Indications Pulmonary hypertension
- Focus Adverse reactions; Therapeutic Use
- Sponsors Pfizer
Most Recent Events
- 09 May 2014 New trial record
- 22 Aug 2012
- 07 Jun 2011